Clinical Trial Update: Impact of Lymphodepletion Regimen on the Response to CAR T-cells in Patients With With Relapsed/Refractory Large B-cell Lymphoma

View source ↗

Summary

This clinical trial update examines whether different lymphodepletion regimens influence the response to CAR T-cell therapy in relapsed/refractory large B-cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large B-cell Lymphoma

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Large B Cell Lymphoma, CAR T Cell | Status: NOT_YET_RECRUITING